Psoriasis and cardiovascular disease

Dermatologic Therapy

Volumn 23, Issue 2, 2010, Pages 144-151

  Vena, Gino A ^a   Vestita, Michelangelo ^a   Cassano, Nicoletta ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Atherosclerosis; Cardiovascular disease; Cardiovascular events; Cardiovascular risk; Inflammation; Psoriasis

Indexed keywords

C REACTIVE PROTEIN; CYCLOSPORIN; METHOTREXATE; OSTEOPONTIN; RETINOID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTERIAL STIFFNESS; ARTERY CALCIFICATION; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DISEASE ASSOCIATION; DISEASE SEVERITY; GENETIC SUSCEPTIBILITY; HEART INFARCTION; HEMOSTASIS; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; INFLAMMATION; INSULIN SENSITIVITY; LIPID METABOLISM; LOW DRUG DOSE; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SIDE EFFECT; STROKE; TH1 CELL; TH17 CELL; THROMBOSIS; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR THROMBOSIS;

ADULT; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COMORBIDITY; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; OSTEOPONTIN; PSORIASIS; RISK FACTORS;

EID: 77950107733     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/j.1529-8019.2010.01308.x     Document Type: Review

References (66)

1. McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol 1978 : 99 : 469 475.
2. Ena P, Madeddu P, Glorioso N, Cerimele D, Rappelli A. High prevalence of cardiovascular diseases and enhanced activity of the renin-angiotensin system in psoriatic patients. Acta Cardiol 1985 : 40 : 199 205.
3. Lindegard B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes. Dermatologica 1986 : 172 : 298 304.
4. Krueger GG, Duvic M. Epidemiology of psoriasis: clinical issues. J Invest Dermatol 1994 : 102 : 14S 18S.
5. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995 : 32 : 982 986.
6. Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis. Arch Dermatol 1999 : 135 : 1490 1493.
7. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006 : 296 : 1735 1741.
8. Kimball AB, Robinson D Jr., Wu Y, et al. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-2002. Dermatology 2008 : 217 : 27 37.
9. Mallbris L, Akre O, Granath F, et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004 : 19 : 225 230.
10. Wakkee M, Herings RM, Nijsten T. Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort. J Invest Dermatol 2009 Oct 8 [Epub ahead of print J, Ford DE. Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample. J Eur Acad Dermatol Venereol 2009 Dec 10 [Epub ahead of print S, Fathy H, Abdelaziz A, et al. Subclinical atherosclerosis in patients with chronic psoriasis: a potential association. J Eur Acad Dermatol Venereol 2009 Nov 2. [Epub ahead of print YB, Jick SS, Miret M, Meier CR. Psoriasis and risk of incident myocardial infarction, stroke or transient ischaemic attack: an inception cohort study with a nested case-control analysis. Br J Dermatol 2009 : 160 : 1048 1056.
11. Ludwig RJ, Herzog C, Rostock A, et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007 : 156 : 271 276.
12. Gisondi P, Fantin F, Del Giglio M, et al. Chronic plaque psoriasis is associated with increased arterial stiffness. Dermatology 2009 : 218 : 110 113.
13. Soy M, Yildiz M, Sevki Uyanik M, et al. Susceptibility to atherosclerosis in patients with psoriasis and psoriatic arthritis as determined by carotid-femoral (aortic) pulse-wave velocity measurement. Rev Esp Cardiol 2009 : 62 : 96 99.
14. Prodanovich S, Kirsner RS, Kravetz JD, Ma F, Martinez L, Federman DG. Association of psoriasis with coronary artery, cerebrovascular, and peripheral vascular diseases and mortality. Arch Dermatol 2009 : 145 : 700 703.
15. Kaye JA, Li L, Jick SS. Incidence of risk factors for myocardial infarction and other vascular diseases in patients with psoriasis. Br J Dermatol 2008 : 159 : 895 902.
16. Gelfand JM, Dommasch ED, Shin DB, et al. The risk of stroke in patients with psoriasis. J Invest Dermatol 2009 : 129 : 2411 2418.
17. Carvalho M, Soares R, Ribeiro F, et al. Perfil ritmico em doentes com artrite psoriatica. Rev Port Cardiol 1990 : 9 : 311 317.
18. Markuszeski L, Bissinger A, Janusz I, Narbutt J, Jedrzejowska AS, Zalewska A. Heart rate and arrhythmia in patients with psoriasis vulgaris. Arch Med Res 2007 : 38 : 64 69.
19. Gunes Y, Tuncer M, Calka O, et al. Increased frequency of pulmonary hypertension in psoriasis patients. Arch Dermatol Res 2008 : 300 : 435 440.
20. Moya JL, Sanchez M, Morales MD, Brito E. Mitral valve prolapse in psoriatic arthritis. Arch Intern Med 1987 : 147 : 992.
21. Muna WF, Roller DH, Craft J, Shaw RK, Ross AM. Psoriatic arthritis and aortic regurgitation. JAMA 1980 : 244 : 363 365.
22. Saricaoglu H, Gullulu S, Bulbul Baskan E, Cordan J, Tunali S. Echocardiographic findings in subjects with psoriatic arthropathy. J Eur Acad Dermatol Venereol 2003 : 17 : 414 417.
23. Biyik I, Narin A, Bozok MA, Ergene O. Echocardiographic and clinical abnormalities in patients with psoriasis. J Int Med Res 2006 : 34 : 632 639.
24. Christophers E. Comorbidities in psoriasis. Clin Dermatol 2007 : 25 : 529 534.
25. Shapiro J, Cohen AD, David M, et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007 : 56 : 629 634.
26. Gonzalez-Juanatey C, Amigo-Diaz E, Miranda-Filloy JA, et al. Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evidentcardiovascular disease or classic atherosclerotic risk factors. Semin Arthritis Rheum 2006 : 35 333 339.
27. Eliakim-Raz N, Shuvy M, Lotan C, Planer D. Psoriasis and dilated cardiomyopathy: coincidence or associated diseases? Cardiology 2008 : 111 : 202 206.
28. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007 : 190 : 1 9.
29. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006 : 298 : 321 328.
30. Gisondi P, Tessari G, Conti A, et al. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study. Br J Dermatol 2007 : 157 : 68 73.
31. Neimann AI, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006 : 55 : 829 835.
32. Herron MD, Hinckley M, Hoffman MS, et al. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005 : 141 : 1527 1534.
33. Fortes C, Mastroeni S, Leffondrè K, et al. Relationship between smoking and the clinical severity of psoriasis. Arch Dermatol 2005 : 141 : 1580 1584.
34. Naldi L. Cigarette smoking and psoriasis. Clin Dermatol 1998 : 16 : 571 574.
35. Setty AR, Curhan G, Choi HK. Smoking and the risk of psoriasis in women: Nurses' Health Study II. Am J Med 2007 : 120 : 953 959.
36. Corbetta S, Angioni R, Cattaneo A, Beck-Peccoz P, Spada A. Effects of retinoid therapy on insulin sensitivity, lipid profile and circulating adipocytokines. Eur J Endocrinol 2006 : 154 : 83 86.
37. Gisondi P, Girolomoni G. Psoriasis and atherothrombotic diseases: disease-specific and non-disease-specific risk factors. Semin Thromb Hemost 2009 : 35 : 313 324.
38. Prodanovich S, Prodanowich S, Ma F. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis. J Am Acad Dermatol 2005 : 52 : 262 267.
39. Dixon WG, Symmons DP. What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology. Ann Rheum Dis 2007 : 66 : 1132 1136.
40. Channual J, Wu JJ, Dann FJ. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis. Dermatol Ther 2009 : 22 : 61 73.
41. Hansson GK, Robertson AK, Söderberg-Nauclér C. Inflammation and atherosclerosis. Annu Rev Pathol 2006 : 1 : 297 329.
42. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006 : 6 : 508 519.
43. Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad Dermatol 2007 : 57 : 347 354.
44. Friedewald VE, Cather JC, Gelfand JM, et al. AJC editor's consensus: psoriasis and coronary artery disease. Am J Cardiol 2008 : 102 : 1631 1643.
45. Prodanovich S, Shelling ML, Federman DG, Kirsner RS. Cytokine milieu in psoriasis and cardiovascular disease may explain the epidemiological findings relating these 2 diseases. Arch Dermatol 2008 : 144 : 1518 1519.
46. Nickoloff BJ. Cracking the cytokine code in psoriasis. Nat Med 2007 : 13 : 242 244.
47. Torti DC, Feldman SR. Interleukin-12, interleukin-23, and psoriasis: current prospects. J Am Acad Dermatol 2007 : 57 : 1059 1068.
48. Ranjbaran H, Sokol SI, Gallo A, et al. An inflammatory pathway of IFN-gamma production in coronary atherosclerosis. J Immunol 2007 : 178 : 592 604.
49. Cheng X, Yu X, Ding YJ, Fu QQ, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008 : 127 : 89 97.
50. Xie JJ, Wang J, Tang TT, et al. The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Cytokine 2009 Oct 26. [Epub ahead of print WY, Cheng BC, Jiang MJ, Hsieh MY, Chang MS. IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2006 : 26 : 2090 2095.
51. Stenderup K, Rosada C, Worsaae A, et al. Interleukin-20 plays a critical role in maintenance and development of psoriasis in the human xenograft transplantation model. Br J Dermatol 2009 : 160 : 284 296.
52. Buback F, Renkl AC, Schulz G, Weiss JM. Osteopontin and the skin: multiple emerging roles in cutaneous biology and pathology. Exp Dermatol 2009 : 18 : 750 759.
53. Cho HJ, Cho HJ, Kim HS. Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification. Curr Atheroscler Rep 2009 : 11 : 206 213.
54. Ohmori R, Momiyama Y, Taniguchi H, et al. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 2003 : 170 : 333 337.
55. Chen YJ, Shen JL, Wu CY, Chang YT, Chen CM, Lee FY. Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis. J Am Acad Dermatol 2009 : 60 : 225 230.
56. Buommino E, Tufano MA, Balato N, et al. Osteopontin: a new emerging role in psoriasis. Arch Dermatol Res 2009 : 301 : 397 404.
57. Naldini A, Leali D, Pucci A, et al. Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes. J Immunol 2006 : 177 : 4267 4270.
58. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 2003 : 107 : 391 397.
59. Guthikonda S, Haynes WG. Homocysteine: role and implications in atherosclerosis. Curr Atheroscler Rep 2006 : 8 : 100 106.
60. Malerba M, Gisondi P, Radaeli A, Sala R, Calzavara Pinton PG, Girolomoni G. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol 2006 : 155 : 1165 1169.
61. Cakmak SK, Gül U, Kiliç C, Gönül M, Soylu S, Kiliç A. Homocysteine, vitamin B12 and folic acid levels in psoriasis patients. J Eur Acad Dermatol Venereol 2009 : 23 : 300 303.
62. Kasperska-Zajac A, Brzoza Z, Rogala B. Platelet function in cutaneous diseases. Platelets 2008 : 19 : 317 321.
63. Ludwig RJ, Schultz JE, Boehncke WH. Activated, not resting, platelets increase leukocyte rolling in murine skin utilizing a distinct set of adhesion molecules. J Invest Dermatol 2004 : 122 : 830 836.
64. Tamagawa-Mineoka R, Katoh N, Ueda E, Masuda K, Kishimoto S. Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of thromboglobulin and platelet factor 4. Allergol Int 2008 : 57 : 391 396.
65. Cassano N, Buquicchio R, Ranieri V, Loconsole F, Vena GA. Is there an association between antiphospholipid antibodies and psoriasis? J Biol Regul Homeost Agents 2008 : 22 : 207 210.
66. Federman DG, Shelling M, Prodanovich S, Gunderson CG, Kirsner RS. Psoriasis: an opportunity to identify cardiovascular risk. Br J Dermatol 2009 : 160 : 1 7.